Anti-DPP-9 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibodies targeting the amino-terminal region of dipeptidyl peptidase 9, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Monkey
UniProt
Q86TI2
Size
100ug
Cat. #
RP3DPP9

In stock

SKU
RP-DPP9

Options

As low as: $130.00

Target Overview

Dipeptidyl peptidase 9 (DPP9, EC 3.4.14.5) is a cytosolic serine protease that cleaves N-terminal dipeptides from substrates with proline or alanine at the P1' position. Encoded by the DPP9 gene, this 863-amino acid enzyme (UniProt Q86TI2) belongs to the prolyl oligopeptidase family and shares structural homology with DPP4 and DPP8. DPP9 localizes primarily to the cytosol and plays a critical non-enzymatic role in innate immunity by suppressing inflammasome activation in resting monocytes and macrophages. Specifically, DPP9 sequesters the cleaved C-terminal fragments of NLRP1 and CARD8 in ternary complexes, preventing their oligomerization and subsequent caspase-1-dependent pyroptosis. While the dipeptidyl peptidase activity is required for this suppressive function, neither NLRP1 nor CARD8 are direct substrates, indicating that DPP9 likely processes upstream regulatory proteins. Researchers study DPP9 in the context of autoinflammatory disease, innate immune signaling, and as a therapeutic target in conditions involving aberrant inflammasome activation.

Background

DPP9 functions as a gatekeeper of innate immune homeostasis through its dual role as both a peptidase and a scaffolding protein. The enzyme cleaves dipeptides from polypeptides with Pro or Ala at position 2, but its most physiologically significant function appears to be the constitutive inhibition of NLRP1 and CARD8 inflammasomes. In resting cells, DPP9 binds the autoproteolytically cleaved C-terminal fragments of these inflammasome sensors, holding them in an inactive state. Loss of DPP9 activity or competitive displacement by small-molecule DPP9 inhibitors triggers rapid NLRP1 and CARD8 oligomerization, leading to caspase-1 activation and pyroptotic cell death. This mechanism explains the inflammatory toxicity observed with certain DPP4/DPP8/DPP9 inhibitors developed for metabolic disease. The requirement for catalytic activity in inflammasome suppression, despite NLRP1 and CARD8 not being direct substrates, suggests DPP9 processes one or more upstream regulatory proteins whose identity remains under investigation. DPP9 knockout studies in mice demonstrate embryonic lethality, underscoring its essential physiological role. In human monocytes and macrophages, DPP9 expression levels directly correlate with the threshold for inflammasome activation, making it a key determinant of innate immune responsiveness. Structurally, DPP9 is an 863-residue protein organized into a catalytic domain and regulatory domains that mediate protein-protein interactions. Three rabbit polyclonal antibodies raised against the amino-terminal region are available from Triple Point Biologics, validated for detection by Western blot, immunohistochemistry, and immunofluorescence in human samples with predicted cross-reactivity in non-human primates.

References

  1. UniProt Consortium. UniProt entry Q86TI2 (DPP9_HUMAN). UniProt Knowledgebase. UniProt

Additional Specifications

Gene Symbol DPP9
UniProt ID Q86TI2
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Monkey
Pack Size 100ug
Immunogen (Aminterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 2-52.
Immunogen (spacer region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 400-550.
Immunogen (Catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 2-863.
Alternate Names DPP9, DP9, Dipeptidyl peptidase 9, Dipeptidyl peptidase IX, DPP IX, Dipeptidyl peptidase IV-related protein 2, DPRP-2, Dipeptidyl peptidase-like protein 9, DPLP9, EC 3.4.14.5

Frequently Asked Questions

What is the expected molecular weight for DPP-9 on Western blot?

Full-length human DPP-9 runs at approximately 98-100 kDa on Western blot, corresponding to the 863-amino acid protein (UniProt Q86TI2). You may observe minor gel-shift variability depending on buffer composition and acrylamide percentage. Post-translational modifications have not been extensively characterized for DPP-9, so additional bands are uncommon but possible in certain cell types. If you detect lower molecular weight species, consider proteolytic processing or degradation during lysis. Use fresh protease inhibitors and keep samples cold to preserve the full-length protein.

What starting dilution should I use for DPP-9 Western blot?

Start at 1:1000 dilution in blocking buffer for overnight incubation at 4°C, which is the validated dilution for this rabbit polyclonal. DPP-9 is a moderately abundant cytosolic protein in most hematopoietic cells, so signal should be detectable without concentration steps. If background is high, you can dilute to 1:2000 or reduce incubation time to 2 hours at room temperature. For low-expressing cell lines, try 1:500 first. Always include a lysate titration alongside antibody optimization to distinguish weak expression from suboptimal conditions.

Does this antibody cross-react with DPP4 or DPP8?

DPP-9 shares significant sequence homology with DPP4 and DPP8, so cross-reactivity is a legitimate concern. This polyclonal was raised against a region spanning residues within the DPP-9 sequence; however, specificity against closely related family members should be confirmed in your system. Run lysates from DPP4-high tissues like kidney or DPP8-expressing controls alongside DPP9-knockout or knockdown samples if available. Single bands at the correct molecular weight in appropriate cell types suggest specificity, but definitive validation requires genetic controls or blocking peptides when paralogs are co-expressed.

Which cell lines or tissues express high levels of DPP-9 for positive controls?

DPP-9 is broadly expressed but particularly abundant in immune cells. Human monocytes, macrophages, and THP-1 cells are reliable positive controls due to DPP-9's role in inflammasome suppression. Peripheral blood mononuclear cells freshly isolated or activated also show robust expression. For tissue lysates, spleen and lymph node typically yield strong signal. Avoid using DPP4-high tissues like kidney or intestine as your only control, since family cross-reactivity could confound interpretation. HEK293T cells express moderate DPP-9 and serve as a transfectable background for overexpression or knockdown experiments.

Can I use this DPP-9 antibody on non-human primate samples?

This antibody shows potential cross-reactivity with monkey DPP-9 based on sequence conservation, but it has not been formally validated in non-human primate lysates. Human and macaque DPP-9 share greater than 95% identity across most epitope regions, so cross-reactivity is probable. If you plan to work with cynomolgus or rhesus samples, run a pilot Western blot at 1:1000 dilution alongside human control lysate. Confirm that the band migrates at the expected molecular weight and that signal is absent in a knockout or pre-immune serum control before committing to full experiments.

What lysis buffer should I use to preserve DPP-9 protein integrity?

DPP-9 is a soluble cytosolic protein, so standard RIPA buffer with protease inhibitors works well. Use freshly added protease inhibitor cocktail and keep samples on ice throughout lysis and clarification. Because DPP-9 contains an active serine protease domain, include serine protease inhibitors like PMSF or AEBSF to prevent autoproteolysis or cleavage of binding partners. Avoid freeze-thaw cycles; aliquot lysates after quantification and store at -80°C. If you plan to study DPP-9 in complex with NLRP1 or CARD8, consider gentler non-denaturing buffers and co-immunoprecipitation-compatible detergents.

How should I store this DPP-9 antibody to maintain activity?

Store the antibody at -20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. After the first thaw, the working aliquot can be kept at 4°C with 0.02-0.05% sodium azide for up to one month if you use it frequently. Do not store diluted antibody in blocking buffer for more than a week; prepare fresh dilutions for critical experiments. If you notice increased background or weak signal over time, thaw a fresh aliquot and compare side-by-side. Rabbit polyclonal antibodies are generally stable for 12-24 months under proper storage conditions.

What is the functional difference between DPP-9 peptidase activity and inflammasome suppression?

DPP-9's dipeptidyl peptidase activity cleaves N-terminal dipeptides from proline- or alanine-containing substrates, but its most studied function is non-enzymatic: sequestering cleaved NLRP1 and CARD8 fragments to prevent inflammasome activation. Importantly, catalytic activity is required for the suppressive function, likely through proper folding or substrate engagement that stabilizes ternary complexes. Neither NLRP1 nor CARD8 are direct cleavage substrates. When probing DPP-9 by Western blot, you detect total protein regardless of enzymatic state. To assess activity, you would need peptidase assays or functional readouts like caspase-1 activation in DPP-9 inhibitor-treated cells.

Western blot validation for RP-DPP9 — 3 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

DPP-9: Aminterminal end — WB validation
WB · Panel 1 DPP-9: Aminterminal end
DPP-9: spacer region — WB validation
WB · Panel 2 DPP-9: spacer region
DPP-9: Catalytic domain — WB validation
WB · Panel 3 DPP-9: Catalytic domain

Custom validation studies available on request — contact us.

Also known as:

  • DPP9
  • DP9
  • Dipeptidyl peptidase 9
  • Dipeptidyl peptidase IX
  • DPP IX
  • Dipeptidyl peptidase IV-related protein 2
  • DPRP-2
  • Dipeptidyl peptidase-like protein 9
  • DPLP9
  • EC 3.4.14.5
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →